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Does a single dose of a homoeopathic ultramolecular dilution of Thyroidinum 
30CH affect the decrease of body weight of fasting patients after Stagnation 
of weight loss? A randomised placebo-controlled double-blind GCP-conforming 
clinical trial 
Schmidt J M , Ostermayr B 
Krankenhaus für Naturheilweisen, Sanatoriumsplatz 2, D-81545 Munich, Germany 
Objectives 
Düring fasting, the daily decrease of body weight is partly 
counteracted by a low triiodothyronine (T3) plasma level 
and a corresponding reduction of protein and fat ca-
tabolism - an adaptation that can be overcome by T3 
treatment. This study investigates whether an ultra-
molecular dilution of thyroid hormone (Thyroidinum 
30CH) affects the course of body weight of fasting 
patients who had encountered a Stagnation of weight 
loss, suggesting an underlying State of hypothyroidism. 
Materials and methods 
Fasting patients encountering a Stagnation of weight 
received either a Single oral dose (five globules) of Thy-
roidinum 30CH or placebo on the same day. Body weight 
and subjective complaints were measured daily, blood 
samples were taken on three successive days. Study rnedi-
cation was administered to 208 patients (intention to 
treat); 14 patients showed minor violations of the pro-
tocol and there were no dropouts. Primary outcome 
parameter was the decrease of body weight 2 days after 
medication; secondary outcome parameters were the 
course of 34 laboratory findings and 15 complaints 
during the following 2-3 days. 
Results 
The decrease of body weight 2 days after medication was 
significantly (P < 0.05) lower in the Thyroidinum group 
(347 ± 304g,n = 102) than in the placebo group (439 ± 
313 g, n ax 106). No striking significant differences were 
found in the laboratory findings and complaints. 
Conclusion 
The results suggest that clinical effects of ultramolecular 
doses may be demonstrated by means of objective para-
meters. Unlike substantial doses, an ultramolecular dose 
of thyroid hormone seems to reduce the decrease of body 
weight of fasting patients 2 days after administration. An 
assumed collateral aggravation of the State of hypo-
thyroidism, however, cannot be supported by plasma 
levels of thyroid hormone, which did not differ signifi-
cantly between the two groups. 
